These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8677893)

  • 1. Prognosis of patients with unstable angina or acute myocardial infarction treated with calcium channel antagonists.
    Ferrari R
    Am J Cardiol; 1996 Jun; 77(16):22D-25D. PubMed ID: 8677893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.
    Held PH; Yusuf S; Furberg CD
    BMJ; 1989 Nov; 299(6709):1187-92. PubMed ID: 2513047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum magnesium levels in patients after myocardial infarction or unstable angina treated with nitrites and calcium antagonists.
    França A; Nogueira Pereira J; Laires MJ; Pereira T; Rabaçal C; Halpern MJ; Simões Fernandes J
    Magnesium; 1985; 4(5-6):291-4. PubMed ID: 3834254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major differences among the three classes of calcium antagonists.
    Ferrari R
    Eur Heart J; 1997 Jan; 18 Suppl A():A56-70. PubMed ID: 9049540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium antagonists and ischemic heart disease].
    Simon K; Vályi P; Szépvölgyi A; Badics A; Böhm T
    Orv Hetil; 1996 Sep; 137(39):2131-6. PubMed ID: 8927361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.
    Yusuf S; Held P; Furberg C
    Am J Cardiol; 1991 Jun; 67(15):1295-7. PubMed ID: 2035457
    [No Abstract]   [Full Text] [Related]  

  • 7. [Calcium, calcium antagonists and coronary insufficiency].
    Lablanche JM; Bertrand ME
    Rev Prat; 1988 Nov; 38(27):1971-4. PubMed ID: 3206147
    [No Abstract]   [Full Text] [Related]  

  • 8. Angina pectoris, myocardial infarction and verapamil.
    Hansen JF; Mellemgaard K
    J Am Coll Cardiol; 1999 Sep; 34(3):957-8. PubMed ID: 10483985
    [No Abstract]   [Full Text] [Related]  

  • 9. Verapamil in acute myocardial infarction. The rationales of the VAMI and DAVIT III trials.
    Jespersen CM
    Cardiovasc Drugs Ther; 1999 Jul; 13(4):301-7. PubMed ID: 10516865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unstable and stable angina.
    Fox KM; Mulcahy D; Purcell H
    Eur Heart J; 1993 Oct; 14 Suppl F():15-7. PubMed ID: 7903242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil in acute myocardial infarction. The rationales of the VAMI and DAVIT III trials.
    Jespersen CM
    Cardiovasc Drugs Ther; 2000 Feb; 14(1):99-105. PubMed ID: 10755209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which calcium channel blocker for ischaemic heart disease?
    Tan K; Lewis S
    Br J Clin Pract; 1992; 46(1):58-62. PubMed ID: 1419556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of calcium channel blocking agents in the management of ischaemic heart disease.
    Braunwald E; Muller JE; Stone PH
    Eur Heart J; 1985 Jan; 6 Suppl A():31-6. PubMed ID: 3996436
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium-channel blockers in ischemic heart disease.
    Silvestry FE; Kimmel SE
    Curr Opin Cardiol; 1996 Jul; 11(4):434-9. PubMed ID: 8879955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug therapy of acute myocardial infarction and unstable coronary syndrome].
    Gjesdal K; Aursnes I
    Tidsskr Nor Laegeforen; 1990 Sep; 110(21):2774-7. PubMed ID: 1977206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does intensive medical therapy influence the outcome in unstable angina?
    Mulcahy R; Conroy R; Katz R; Fitzpatrick M
    Clin Cardiol; 1990 Oct; 13(10):687-9. PubMed ID: 1979527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of other drugs apart from antithrombotic and antiplatelet agents for the treatment of non-ST-elevation acute coronary syndromes].
    Birdane A; Ata N
    Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():30-4. PubMed ID: 16613773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists--clinical considerations.
    Prisant LM
    Ethn Dis; 1998; 8(1):124-7. PubMed ID: 9595257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why Ca2+ antagonists will be most useful before or during early myocardial ischaemia and not after infarction has been established.
    Hugenholtz PG; Serruys PW; Fleckenstein A; Nayler W
    Eur Heart J; 1986 Apr; 7(4):270-8. PubMed ID: 2873037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.